Published in Arch Dermatol on January 01, 1987
A case of leukemia cutis at the site of a prior catheter insertion. Ann Dermatol (2009) 0.93
Clearing of epidermolysis bullosa acquisita with cyclosporine. J Am Acad Dermatol (1988) 2.00
Differentiating anti-lamina lucida and anti-sublamina densa anti-BMZ antibodies by indirect immunofluorescence on 1.0 M sodium chloride-separated skin. J Invest Dermatol (1984) 1.85
Identification of the skin basement-membrane autoantigen in epidermolysis bullosa acquisita. N Engl J Med (1984) 1.80
Cutaneous plasmacytomas. A review and presentation of an unusual case. J Am Acad Dermatol (1979) 1.38
An in vitro model of immune complex-mediated basement membrane zone separation caused by pemphigoid antibodies, leukocytes, and complement. J Invest Dermatol (1982) 1.23
Comparative efficacy of oral erythromycin versus oral tetracycline in the treatment of acne vulgaris. A double-blind study. J Am Acad Dermatol (1986) 1.17
A case of linear IgA disease presenting initially with IgG immune deposits. J Am Acad Dermatol (1986) 1.14
Epiligrin, the major human keratinocyte integrin ligand, is a target in both an acquired autoimmune and an inherited subepidermal blistering skin disease. J Clin Invest (1992) 1.09
In vivo suppression of neutrophil chemotaxis by systemically and topically administered tetracycline. J Am Acad Dermatol (1983) 1.09
Pemphigoid antibody mediated attachment of peripheral blood leukocytes at the dermal-epidermal junction of human skin. J Invest Dermatol (1980) 1.08
Epidermolysis bullosa acquisita antigen, a major cutaneous basement membrane component, is synthesized by human dermal fibroblasts and other cutaneous tissues. J Invest Dermatol (1986) 1.05
Mechanism of lesion production in pemphigus and pemphigoid. J Am Acad Dermatol (1982) 1.04
Epidermolysis bullosa acquisita--a pemphigoid-like disease. J Am Acad Dermatol (1984) 0.99
A mouse monoclonal antibody against a newly discovered basement membrane component, the epidermolysis bullosa acquisita antigen. J Invest Dermatol (1985) 0.98
Epidermolysis bullosa acquisita antigen is synthesized by human keratinocytes cultured in serum-free medium. Biochem Biophys Res Commun (1985) 0.93
The neonatal lupus syndrome associated with U1RNP (nRNP) antibodies. N Engl J Med (1987) 0.92
Immunodominant autoepitopes of type VII collagen are short, paired peptide sequences within the fibronectin type III homology region of the noncollagenous (NC1) domain. J Invest Dermatol (1995) 0.92
Direct immunofluorescence microscopy of 1 mol/L sodium chloride-treated patient skin. J Am Acad Dermatol (1991) 0.88
Differences in complement-dependent chemotactic activity generated by bullous pemphigoid and epidermolysis bullosa acquisita immune complexes: demonstration by leukocytic attachment and organ culture methods. J Invest Dermatol (1984) 0.88
Epidermolysis bullosa acquisita antigen, a new major component of cutaneous basement membrane, is a glycoprotein with collagenous domains. J Invest Dermatol (1986) 0.88
Bullous systemic lupus erythematosus. J Am Acad Dermatol (1982) 0.87
Passive transfer of autoantibodies from a patient with mutilating epidermolysis bullosa acquisita induces specific alterations in the skin of neonatal mice. Arch Dermatol (1995) 0.86
Evidence that anti-basement membrane zone antibodies in bullous eruption of systemic lupus erythematosus recognize epidermolysis bullosa acquisita autoantigen. J Invest Dermatol (1985) 0.86
Cutaneous IgA deposits in bullous diseases function as ligands to mediate adherence of activated neutrophils. J Invest Dermatol (1990) 0.85
Specific affinity between fibronectin and the epidermolysis bullosa acquisita antigen. J Clin Invest (1987) 0.85
Antiepiligrin cicatricial pemphigoid. A subepithelial bullous disorder. Arch Dermatol (1994) 0.85
Production of fibronectin by epithelium in a skin equivalent. J Invest Dermatol (1987) 0.84
Epidermolysis bullosa acquisita of the immunopathological type (dermolytic pemphigoid). J Invest Dermatol (1985) 0.84
The presence of intra-lamina lucida blister formation in epidermolysis bullosa acquisita: possible role of leukocytes. J Invest Dermatol (1989) 0.84
Organ-specific, phylogenetic, and ontogenetic distribution of the epidermolysis bullosa acquisita antigen. J Invest Dermatol (1986) 0.83
Childhood epidermolysis bullosa acquisita. Report of three cases and review of literature. J Am Acad Dermatol (1991) 0.83
Functional evidence for complement-activating immune complexes in the skin of patients with bullous pemphigoid. J Invest Dermatol (1982) 0.83
Systemic lupus erythematosus presenting as a bullous eruption in a child. Arch Dermatol (1988) 0.82
The carboxyl-terminal domain of type VII collagen is present at the basement membrane in recessive dystrophic epidermolysis bullosa. J Invest Dermatol (1989) 0.82
Leukocyte chemotaxis to the dermal-epidermal junction of human skin mediated by pemphigoid antibody and complement: mechanism of cell attachment in the in vitro leukocyte attachment method. J Invest Dermatol (1981) 0.82
Demonstration of the complement regulating protein, beta 1H, in skin biopsies from patients with bullous pemphigoid. J Invest Dermatol (1979) 0.81
Epidermolysis bullosa acquisita presenting as an inflammatory bullous disease. J Am Acad Dermatol (1982) 0.80
A bullous skin disease patient with autoantibodies against separate epitopes in 1 mol/L sodium chloride split skin. Arch Dermatol (1992) 0.80
Inhibition of neutrophil adherence to antibody by dapsone: a possible therapeutic mechanism of dapsone in the treatment of IgA dermatoses. J Invest Dermatol (1993) 0.80
Secondary cutaneous mucinosis with systemic lupus erythematosus. A case presentation and review of the literature. Arch Dermatol (1978) 0.78
A comparison of Cleocin T Solution, Cleocin T Gel, and placebo in the treatment of acne vulgaris. Cutis (1988) 0.77
Bullous systemic lupus erythematosus: an unusual clinical course and detectable circulating autoantibodies to the epidermolysis bullosa acquisita antigen. J Am Acad Dermatol (1986) 0.76
Epidermolysis bullosa acquisita in a patient with multiple endocrinopathies syndrome. Arch Dermatol (1986) 0.76
Acquired epidermolysis bullosa. A bullous disease associated with autoimmunity to type VII (anchoring fibril) collagen. Dermatol Clin (1990) 0.76
Heavy and light chain isotypes of immunoglobulin in epidermolysis bullosa acquisita. J Invest Dermatol (1990) 0.76
Relationship of beta 1H globulin and cleavage fragments of the third component of complement in the skin of patients with bullous pemphigoid and dermatitis herpetiformis. Clin Immunol Immunopathol (1981) 0.76
Unilateral Muehrcke's lines following trauma. Arch Dermatol (1989) 0.75
Normal molecular weight of type VII collagen produced by recessive dystrophic epidermolysis bullosa keratinocytes. J Invest Dermatol (1993) 0.75
Complement-activating immune deposits in systemic lupus erythematosus skin. J Invest Dermatol (1983) 0.75
Urticarial vasculitis. Dermatol Clin (1985) 0.75
Epidermolysis bullosa acquista. Immunol Ser (1989) 0.75
Urticarial vasculitis: report of a case and review of the literature. Arch Dermatol (1979) 0.75
Epidermolysis bullosa acquisita: an autoimmune disease with distinctive immunoultrastructural features. Cutis (1983) 0.75
Evidence supporting a role for immune complex-mediated inflammation in the pathogenesis of bullous lesions of systemic lupus erythematosus. J Invest Dermatol (1983) 0.75
Immune complex-mediated complement activation in bullous pemphigoid. Clin Dermatol (1987) 0.75
Neonatal foreskin substrate has limitations for the immunofluorescent screening of monoclonal antibodies. J Invest Dermatol (1987) 0.75
Seasonal alopecia areata with atopy. J Am Acad Dermatol (1989) 0.75
A blistering eruption associated with Wilson's disease. J Am Acad Dermatol (1989) 0.75
Experimental cutaneous candidiasis in rodents. Arch Dermatol (1979) 0.75
Epidermolysis bullosa acquisita preceding the development of systemic lupus erythematosus. J Am Acad Dermatol (1990) 0.75
Pustular eruption of the striae in a primigravida. Cutis (1992) 0.75
Placental glutathione-S-transferase-pi mRNA is abundantly expressed in human skin. J Invest Dermatol (1990) 0.75
Double immunofluorescence microscopy: a method for localizing immune deposits in skin diseases associated with linear basement membrane zone immunofluorescence. J Invest Dermatol (1982) 0.75
Multiple clear cell acanthomas. Case report and delineation of basement membrane zone antigens. J Am Acad Dermatol (1987) 0.75
Phagocyte chemotaxis. J Invest Dermatol (1979) 0.75
Kyrle's disease and hepatic insufficiency. Arch Dermatol (1986) 0.75
Survival of herpes simplex virus during cryosurgery with liquid nitrogen. J Dermatol Surg Oncol (1986) 0.75
Studies on complement deposits in epidermolysis bullosa acquisita and bullous pemphigoid. Arch Dermatol (1992) 0.75
A functional assay for complement-activating antibodies to the cutaneous basement membrane zone. Ann N Y Acad Sci (1983) 0.75
Characterization of the changes in matrix molecules at the dermoepidermal junction in lupus erythematosus. J Cutan Pathol (1991) 0.75